Press Coverage
Sofinnova Crossover
Tom Burt, partner at Sofinnova Partners, speaks at Edison Group’s Open House Global Healthcare Event
Related Strategy
CrossoverTom Burt, partner at Sofinnova Partners, joined Edison Group’s Open House Global Healthcare Event. His panel discussed some of the scenarios that are likely to play out in 2022 for biotech in public and private equity markets and M&A. View the replay here.
Related News
Abivax announces full year 2025 financial results and provides business updates
Sensorion reports six-month update from the Audiogene Phase 1/2 Trial of SENS-501 and advances GJB2-GT (SENS-601) toward first-in-human clinical development
GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments
Sensorion announces leadership changes
Artios strengthens leadership team to accelerate late-stage development of potential first-in-class oncology pipeline